Literature DB >> 20862907

Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature review.

Kim Boswell1, Winghan Jacqueline Kwong, Shane Kavanagh.   

Abstract

Opioid analgesia is the mainstay of treatment for moderate to severe acute and chronic pain and is highly effective in relieving pain but can be limited by side effects, the most common of which affect the gastrointestinal (GI) and central nervous systems. A growing body of evidence demonstrates that opioid-associated GI side effects constitute an important health problem with significant humanistic and economic consequences that warrant consideration by healthcare professionals and administrators in optimizing patients' pain management. This article documents the frequency of opioid-associated GI side effects and describes its clinical and economic burdens based on a systematic review of the medical literature between 1966 and 2008.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862907     DOI: 10.5055/jom.2010.0025

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  7 in total

1.  Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR.

Authors:  Andrew Paris; Chris M Kozma; Wing Chow; Anisha M Patel; Samir H Mody; Myoung S Kim
Journal:  Am Health Drug Benefits       Date:  2013-11

Review 2.  Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity.

Authors:  Helga Radner; Sofia Ramiro; Rachelle Buchbinder; Robert B M Landewé; Désirée van der Heijde; Daniel Aletaha
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

3.  Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review.

Authors:  Karin S Coyne; Robert J LoCasale; Catherine J Datto; Chris C Sexton; Karen Yeomans; Jan Tack
Journal:  Clinicoecon Outcomes Res       Date:  2014-05-23

4.  A phase 3, randomized, double-blind comparison of analgesic efficacy and tolerability of Q8003 vs oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery.

Authors:  Patricia Richards; Dennis Riff; Robin Kelen; Warren Stern
Journal:  Pain Med       Date:  2013-06-26       Impact factor: 3.750

5.  Analgesic Efficacy and Safety of Prolonged-Release Oxycodone/Naloxone in Korean Patients with Chronic Pain from Spinal Disorders.

Authors:  Chang Ju Hwang; Sung Soo Chung; Kyu-Yeol Lee; Jae Hyup Lee; Seong-Hwan Moon; Jin-Hyok Kim; Kyu-Jung Cho; Jae-Sung Ahn; Dong-Soo Kim; Ye-Soo Park; Hye-Jeong Park
Journal:  Clin Orthop Surg       Date:  2018-02-27

Review 6.  Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.

Authors:  Ricard Mesía; Juan Antonio Virizuela Echaburu; Jose Gómez; Tamara Sauri; Gloria Serrano; Eduardo Pujol
Journal:  Curr Treat Options Oncol       Date:  2019-12-19

7.  Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain.

Authors:  Karin S Coyne; Chris Sexton; Robert J LoCasale; Frederic R King; Mary Kay Margolis; Sam H Ahmedzai
Journal:  Front Oncol       Date:  2016-06-08       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.